These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31185062)

  • 21. Quantifying drug-related 5-HT1A receptor occupancy with.
    Passchier J; van Waarde A; Pieterman RM; Willemsen AT; Vaalburg W
    Psychopharmacology (Berl); 2001 May; 155(2):193-7. PubMed ID: 11401009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GABA
    Kessler M; Mamach M; Beutelmann R; Lukacevic M; Eilert S; Bascuñana P; Fasel A; Bengel FM; Bankstahl JP; Ross TL; Klump GM; Berding G
    Mol Imaging Biol; 2020 Apr; 22(2):335-347. PubMed ID: 31102039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased serotonin receptor availability in human sleep: evidence from an [18F]MPPF PET study in narcolepsy.
    Derry C; Benjamin C; Bladin P; le Bars D; Tochon-Danguy H; Berkovic SF; Zimmer L; Costes N; Mulligan R; Reutens D
    Neuroimage; 2006 Apr; 30(2):341-8. PubMed ID: 16275016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PET imaging of brain 5-HT1A receptors in rat in vivo with 18F-FCWAY and improvement by successful inhibition of radioligand defluorination with miconazole.
    Tipre DN; Zoghbi SS; Liow JS; Green MV; Seidel J; Ichise M; Innis RB; Pike VW
    J Nucl Med; 2006 Feb; 47(2):345-53. PubMed ID: 16455642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between triallelic polymorphism of the serotonin transporter and [18F]MPPF binding potential at 5-HT1A receptors in healthy subjects.
    Lothe A; Boni C; Costes N; Gorwood P; Bouvard S; Le Bars D; Lavenne F; Ryvlin P
    Neuroimage; 2009 Aug; 47(2):482-92. PubMed ID: 19409499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclosporine, a P-glycoprotein modulator, increases [18F]MPPF uptake in rat brain and peripheral tissues: microPET and ex vivo studies.
    Laćan G; Plenevaux A; Rubins DJ; Way BM; Defraiteur C; Lemaire C; Aerts J; Luxen A; Cherry SR; Melega WP
    Eur J Nucl Med Mol Imaging; 2008 Dec; 35(12):2256-66. PubMed ID: 18604533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 18F-Mefway PET imaging of serotonin 1A receptors in humans: a comparison with 18F-FCWAY.
    Choi JY; Lyoo CH; Kim JS; Kim KM; Kang JH; Choi SH; Kim JJ; Ryu YH
    PLoS One; 2015; 10(4):e0121342. PubMed ID: 25830772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased [18F]MPPF binding potential in the dorsal raphe nucleus after a single oral dose of fluoxetine: a positron-emission tomography study in healthy volunteers.
    Sibon I; Benkelfat C; Gravel P; Aznavour N; Costes N; Mzengeza S; Booij L; Baker G; Soucy JP; Zimmer L; Descarries L
    Biol Psychiatry; 2008 Jun; 63(12):1135-40. PubMed ID: 18191817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 5-HT1A sex based differences in Bmax, in vivo KD, and BPND in the nonhuman primate.
    Wooten DW; Hillmer AT; Moirano JM; Tudorascu DL; Ahlers EO; Slesarev MS; Barnhart TE; Mukherjee J; Schneider ML; Christian BT
    Neuroimage; 2013 Aug; 77():125-32. PubMed ID: 23537936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantification of dopamine transporter density with [18F]FECNT PET in healthy humans.
    Nye JA; Votaw JR; Bremner JD; Davis MR; Voll RJ; Camp VM; Goodman MM
    Nucl Med Biol; 2014 Mar; 41(3):217-22. PubMed ID: 24533985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estimation of the binding potential BP
    Schain M; Zanderigo F; Mann JJ; Ogden RT
    Neuroimage; 2017 Feb; 146():121-131. PubMed ID: 27856316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. First-in-human PET quantification study of cerebral α4β2* nicotinic acetylcholine receptors using the novel specific radioligand (-)-[(18)F]Flubatine.
    Sabri O; Becker GA; Meyer PM; Hesse S; Wilke S; Graef S; Patt M; Luthardt J; Wagenknecht G; Hoepping A; Smits R; Franke A; Sattler B; Habermann B; Neuhaus P; Fischer S; Tiepolt S; Deuther-Conrad W; Barthel H; Schönknecht P; Brust P
    Neuroimage; 2015 Sep; 118():199-208. PubMed ID: 26037057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of serotonin 5-HT(1A) receptors in rodent models using [¹⁸F]mefway PET.
    Saigal N; Bajwa AK; Faheem SS; Coleman RA; Pandey SK; Constantinescu CC; Fong V; Mukherjee J
    Synapse; 2013 Sep; 67(9):596-608. PubMed ID: 23504990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantification of SV2A Binding in Rodent Brain Using [
    Sadasivam P; Fang XT; Toyonaga T; Lee S; Xu Y; Zheng MQ; Spurrier J; Huang Y; Strittmatter SM; Carson RE; Cai Z
    Mol Imaging Biol; 2021 Jun; 23(3):372-381. PubMed ID: 33258040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetic Evaluation of the Tau PET Radiotracer
    Wooten DW; Guehl NJ; Verwer EE; Shoup TM; Yokell DL; Zubcevik N; Vasdev N; Zafonte RD; Johnson KA; El Fakhri G; Normandin MD
    J Nucl Med; 2017 Mar; 58(3):484-491. PubMed ID: 27660144
    [No Abstract]   [Full Text] [Related]  

  • 36. Test-retest reliability of the novel 5-HT1B receptor PET radioligand [11C]P943.
    Saricicek A; Chen J; Planeta B; Ruf B; Subramanyam K; Maloney K; Matuskey D; Labaree D; Deserno L; Neumeister A; Krystal JH; Gallezot JD; Huang Y; Carson RE; Bhagwagar Z
    Eur J Nucl Med Mol Imaging; 2015 Mar; 42(3):468-77. PubMed ID: 25427881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantification of TSPO overexpression in a rat model of local neuroinflammation induced by intracerebral injection of LPS by the use of [(18)F]DPA-714 PET.
    Ory D; Postnov A; Koole M; Celen S; de Laat B; Verbruggen A; Van Laere K; Bormans G; Casteels C
    Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):163-172. PubMed ID: 26323575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interictal brain 5-HT1A receptors binding in migraine without aura: a 18F-MPPF-PET study.
    Lothe A; Merlet I; Demarquay G; Costes N; Ryvlin P; Mauguière F
    Cephalalgia; 2008 Dec; 28(12):1282-91. PubMed ID: 18727636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uptake and binding of the serotonin 5-HT1A antagonist [18F]-MPPF in brain of rats: effects of the novel P-glycoprotein inhibitor tariquidar.
    la Fougère C; Böning G; Bartmann H; Wängler B; Nowak S; Just T; Wagner E; Winter P; Rominger A; Förster S; Gildehaus FJ; Rosa-Neto P; Minuzzi L; Bartenstein P; Potschka H; Cumming P
    Neuroimage; 2010 Jan; 49(2):1406-15. PubMed ID: 19796699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Organic background of restrictive-type anorexia nervosa suggested by increased serotonin 1A receptor binding in right frontotemporal cortex of both lean and recovered patients: [18F]MPPF PET scan study.
    Galusca B; Costes N; Zito NG; Peyron R; Bossu C; Lang F; Le Bars D; Estour B
    Biol Psychiatry; 2008 Dec; 64(11):1009-13. PubMed ID: 18639866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.